Gene Therapy Trials for Hemophilia A

Gene Therapy Trials for Hemophilia A: Where We Are and What Comes Next

Here’s what we’ll discuss

A general overview of the clinical trial process
Details on the design of the BioMarin gene therapy clinical trial program for hemophilia A (BMN 270) and its current progress
BioMarin's approach to advocacy for the hemophilia community

WATCH THE VIDEO

Interested in expanding your knowledge?

Are you a U.S. resident?

This content is intended for US participants only.

Yes

First Name

Last Name

Email Address

Phone Number

Zip Code

By checking this box and clicking SIGN UP below, I confirm I am at least 18 years old; confirm I agree to BioMarin’s Privacy Policy and CCPA Notice and Terms of Use; consent to BioMarin, its successors, agents, and/or assigns using the email address I have provided to keep me informed about news and developments, market research or surveys, or other opportunities that may be of interest to me; and confirm I understand these communications/materials may contain information that markets or advertises BioMarin products, goods, or services.

By checking this box and clicking SIGN UP below, I consent to BioMarin, its successors, agents, and/or assigns using the phone number I have provided to phone and/or text me with communications/messages that contain information marketing BioMarin’s products, goods, or services, including via use of an automatic telephone dialing system; and confirm I understand I am not required to provide my consent as a condition of purchasing or renting any products, goods, or services.

Please Verify Captcha!